BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17569404)

  • 21. Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis.
    Seite S; Rougier A; Talarico S
    J Cosmet Dermatol; 2009 Dec; 8(4):249-53. PubMed ID: 19958427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial.
    Sofen H; Hudson CP; Cook-Bolden FE; Preston N; Colón LE; Colón LE; Caveney SW; Gottschalk RW
    J Drugs Dermatol; 2011 Aug; 10(8):885-92. PubMed ID: 21818510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open-label pilot study of naftifine 1% gel in the treatment of seborrheic dermatitis of the scalp.
    Gold MH; Bridges T; Avakian EV; Plaum S; Fleischer AB; Hardas B
    J Drugs Dermatol; 2012 Apr; 11(4):514-8. PubMed ID: 22453590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A lipohydroxyacid-containing shampoo improves scalp condition and quality of life in patients with seborrheic dermatitis and light-to-moderate scalp psoriasis.
    Seité S; Paries J; Reygagne P; Hamidou Z; Jouanique C; Perez-Pala G; Rougier A
    J Cosmet Dermatol; 2009 Jun; 8(2):108-13. PubMed ID: 19527334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.
    Katz HI; Lindholm JS; Weiss JS; Shavin JS; Morman M; Bressinck R; Cornell R; Pariser DM; Pariser RJ; Weng W
    Clin Ther; 1995; 17(3):390-401. PubMed ID: 7585843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis.
    Mazzotta A; Esposito M; Carboni I; Schipani C; Chimenti S
    J Dermatolog Treat; 2007; 18(2):84-7. PubMed ID: 17520464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciclopirox shampoo for treating seborrheic dermatitis.
    Gupta AK; Bluhm R
    Skin Therapy Lett; 2004; 9(6):4-5. PubMed ID: 15334279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of 1% ciclopirox shampoo in the treatment of moderate-to-severe scalp seborrheic dermatitis: a multicenter, prospective, assessor-blinded trial.
    Veraldi S; Barbareschi M; Martella A; Milani M
    G Ital Dermatol Venereol; 2019 Jun; 154(3):342-346. PubMed ID: 31001967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous clinical improvement of mild-to-moderate seborrheic dermatitis and rebalancing of the scalp microbiome using a selenium disulfide-based shampoo after an initial treatment with ketoconazole.
    Massiot P; Clavaud C; Thomas M; Ott A; Guéniche A; Panhard S; Muller B; Michelin C; Kerob D; Bouloc A; Reygagne P
    J Cosmet Dermatol; 2022 May; 21(5):2215-2225. PubMed ID: 34416081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clobetasol propionate 0.05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial.
    Vena GA; Cassano N; D'Argento V; Milani M
    Br J Dermatol; 2006 Feb; 154(2):353-6. PubMed ID: 16433809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis.
    Piérard-Franchimont C; Goffin V; Decroix J; Piérard GE
    Skin Pharmacol Appl Skin Physiol; 2002; 15(6):434-41. PubMed ID: 12476017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff.
    Danby FW; Maddin WS; Margesson LJ; Rosenthal D
    J Am Acad Dermatol; 1993 Dec; 29(6):1008-12. PubMed ID: 8245236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments.
    Piérard-Franchimont C; Piérard GE; Arrese JE; De Doncker P
    Dermatology; 2001; 202(2):171-6. PubMed ID: 11306850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial.
    Peter RU; Richarz-Barthauer U
    Br J Dermatol; 1995 Mar; 132(3):441-5. PubMed ID: 7718463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis.
    Beutner K; Chakrabarty A; Lemke S; Yu K
    J Drugs Dermatol; 2006 Apr; 5(4):357-60. PubMed ID: 16673804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selenium Disulfide-based shampoo applied for 4 weeks significantly improves dandruff and seborrheic dermatitis.
    Turcu G; Artenie C; Nowicka D; Arenbergerová M; Lazaridou E; Khobzei K; Ataseven A; Part M; Leclerc-Mercier S
    Eur J Dermatol; 2023 Mar; 33(S1):19-23. PubMed ID: 37098775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketoconazole shampoo for dandruff.
    Med Lett Drugs Ther; 1994 Jul; 36(927):68. PubMed ID: 8022364
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical effectiveness and tolerance of climbazole containing dandruff shampoo in patients with seborrheic scalp eczema].
    Wigger-Alberti W; Kluge K; Elsner P
    Praxis (Bern 1994); 2001 Aug; 90(33):1346-9. PubMed ID: 11534318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea.
    Lee JH; Lee HS; Eun HC; Cho KH
    J Dermatolog Treat; 2003 Dec; 14(4):212-5. PubMed ID: 14660265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
    Feldman SR; Koo JY; Johnson LA; Preston NJ
    Cutis; 2009 Oct; 84(4 Suppl):25-32. PubMed ID: 19916299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.